RESIDUAL DISEASE
Clinical trials for RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to stop breast cancer from returning
Disease control Recruiting nowThis study tests whether adding tetrathiomolybdate (TM) to standard capecitabine can lower the chance of breast cancer returning in patients with high-risk triple-negative breast cancer. About 204 participants who have completed initial treatment and surgery will receive either T…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated May 26, 2026 02:13 UTC
-
Blood test catches hidden breast cancer before scans can see it
Disease control Recruiting nowThis study is for people with a high-risk type of breast cancer (triple-negative) who still have cancer cells left after standard chemotherapy and surgery. Researchers will use a simple blood test to look for tiny bits of cancer DNA (ctDNA) that might signal the cancer is coming …
Matched conditions: RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 02:11 UTC